| Term 
 | Definition 
 
        | Muscarinic Antagonist 
 long duration of action
 
 Belladona alkaloid
 
 Clinical use:
 parkinson's disease
 mydriasis
 cycloplegia
 acute rhinitis
 
 preoperative medication
 hyperactive carotid sinus syndrome
 vagal-induced heart block
 parathion/mushroom poisioning
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Muscarinic Antagonist 
 long duration of action
 belladona alkaloid
 
 Clinical use:
 parkinson's disease
 mydriasis
 cycloplegia
 acute rhinitis
 
 preoperative medication
 motion sickness (b/c has best CNS vs. peripheral effects)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Muscarinic Antagonist 
 -short duration of action
 Clinical use:
 parkinson's disease
 mydriasis
 cycloplegia
 acute rhinitis
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Muscarinic Antagonist 
 Clinical use:
 parkinson's disease
 mydriasis
 cycloplegia
 acute rhinitis
 asthma/COPD
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Muscarinic Antagonist 
 Clinical use:
 parkinson's disease
 mydriasis
 cycloplegia
 acute rhinitis
 asthma/COPD
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Muscarinic Antagonist 
 Clinical use:
 parkinson's disease
 mydriasis
 cycloplegia
 acute rhinitis
 
 overactive bladder or urge incontinence (from detrusor overactivity or instability)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Muscarinic Antagonist 
 Clinical use:
 parkinson's disease
 mydriasis
 cycloplegia
 acute rhinitis
 
 overactive bladder or urge incontinence (from detrusor overactivity or instability)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Muscarinic Antagonist 
 Clinical use:
 parkinson's
 mydriasis
 cycloplegia
 acute rhinitis
 
 overactive bladder or urge incontinence (from detrusor overactivity or instability)
 |  | 
        |  | 
        
        | Term 
 
        | what's the MOA for muscarinic antagonists? |  | Definition 
 
        | competitive, reversible muscarinic blockers |  | 
        |  | 
        
        | Term 
 
        | what's the order of blockade for muscarinic antagonists? |  | Definition 
 
        | salivary, bronchial, sweat glands--> iris, ciliary m., heart-->bladder, gut-->gastric acid secretion |  | 
        |  | 
        
        | Term 
 
        | what's the problem in using muscarinic antagonists to treat ulcers? |  | Definition 
 
        | need high [ ]; too many side effects |  | 
        |  | 
        
        | Term 
 
        | what drugs cause mydirasis? |  | Definition 
 
        | Tropicamide; alpha1 agonist |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | lens is fixed for far vision 
 -muscarinic receptors on ciliary m. are blocked and prevent ciliary m. from contracting
 |  | 
        |  | 
        
        | Term 
 
        | How can muscarinic antaognists be used for acute rhinitis? |  | Definition 
 
        | blocks muscarinic recpetors on nasopharyngeal glands and decreases secretion in the respiratory tract 
 (alpha1 agonist used for nasal congestion; reduced swelling; won't dry up secretions)
 |  | 
        |  | 
        
        | Term 
 
        | what is the advantage of using ipratropium bromide as opposed to atropine? |  | Definition 
 
        | won't be absorbed as well (because it's charged) so will have less systemic side effects |  | 
        |  | 
        
        | Term 
 
        | Why would ipratropium bromide be used in COPD/asthma patients? |  | Definition 
 
        | blocks muscarinic receptors and thus causes bronchodilation |  | 
        |  | 
        
        | Term 
 
        | Would a B2 agonist or ipratropium bromide be better for asthma? |  | Definition 
 
        | may have minimal bronchoconstriction from PS activity so ipratropium bromide < B2 agonist |  | 
        |  | 
        
        | Term 
 
        | would a B2 agonist or ipratropium bromide be better for COPD? |  | Definition 
 
        | ipratropium bromide=B2 agonist because may have significant PS mediated bronchoconstriction 
 Advantages of Ipratropium bromide:
 -increase in cholinergic tone is a major reversible component of COPD
 -usually less side effects than beta agonists (beta agonists would raise bp, etc)
 |  | 
        |  | 
        
        | Term 
 
        | Which drug affects the brain the most and thus tends to be used most often? |  | Definition 
 
        | scopolamine 
 scopolamine > atropine
 
 -therapeutic doses of scopolamine can cause CNS depression-drowsiness, amnesia, fatigue, dreamless sleep
 |  | 
        |  | 
        
        | Term 
 
        | what's the advantage of using atropine versus something that would increase HR (e.g. Epi)? |  | Definition 
 
        | potentially less side effects (e.g. BP, etc) |  | 
        |  | 
        
        | Term 
 
        | Atropine has no effect on ventricular arrhythmias. Why? |  | Definition 
 
        | few M receptors in the ventricles |  | 
        |  | 
        
        | Term 
 
        | How does scopolamine prevent motion sickeness? |  | Definition 
 
        | vestibular apparatus--> M receptor in medulla (vomit center); blocks the M receptor and thus prevents motion sickness |  | 
        |  | 
        
        | Term 
 
        | What drug class has contraindication of dry as a bone, blind as a bat, red as a beet, mad as a hatter? |  | Definition 
 
        | muscarinic anatagonist 
 
 can get CNS toxicities:
 -sedation or excitement
 -disorientation, memory disturbances, dizziness, restlessness, hallucinations, delirium, confusion
 
 scopolamine>atropine>>>>ipratropium
 |  | 
        |  | 
        
        | Term 
 
        | what is narrow angle glacuoma a contraindication for? |  | Definition 
 | 
        |  |